The first Health Technology Assessment for the Acute Treatment of Migraine Attacks and Prevention has been published in Cephalalgia by the Clinical Trials Subcommittee of the International Headache Society.
The researchers’ goal was to provide an overview of endpoints and outcomes in the current acute migraine clinical trial literature to facilitate the development of novel treatments.
Study authors described the characteristics of youth with post-traumatic headache and determined whether the PTH phenotype was associated with outcome.
The purpose of this study was to evaluate the subsequent health resource utilization (HRU) of patients with migraine who received opioid medications at ED visits.
